(0.07%) 5 473.03 points
(0.10%) 39 152 points
(0.37%) 17 783 points
(0.15%) $80.95
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.25%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.69%) $10.68
(0.44%) $0.792
(-0.28%) $87.24
Live Chart Being Loaded With Signals
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States...
Stats | |
---|---|
今日成交量 | 656 224 |
平均成交量 | 2.02M |
市值 | 0.00 |
EPS | $-0.450 ( Q2 | 2022-08-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-25.93 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.378 (0.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-20 | Jain Rita | Sell | 11 600 | Restricted Stock Unit |
2022-10-20 | Herron Jennifer Lyn | Sell | 17 237 | Common Stock |
2022-10-20 | Edwards Thomas A. | Sell | 15 723 | Restricted Stock Unit |
2022-10-20 | Parker Geoffrey M. | Sell | 15 723 | Restricted Stock Unit |
2022-10-20 | Kanaya Susan M | Sell | 90 968 | Restricted Stock Unit |
INSIDER POWER |
---|
-78.69 |
Last 97 transactions |
Buy: 1 451 999 | Sell: 1 420 462 |
音量 相关性
ChemoCentryx, Inc. 相关性
10 最正相关 | |
---|---|
SANB | 0.835 |
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
ChemoCentryx, Inc. 相关性 - 货币/商品
ChemoCentryx, Inc. 财务报表
Annual | 2021 |
营收: | $32.22M |
毛利润: | $31.92M (99.06 %) |
EPS: | $-1.890 |
FY | 2021 |
营收: | $32.22M |
毛利润: | $31.92M (99.06 %) |
EPS: | $-1.890 |
FY | 2020 |
营收: | $64.89M |
毛利润: | $64.89M (100.00 %) |
EPS: | $-0.840 |
FY | 2019 |
营收: | $35.95M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.980 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ChemoCentryx, Inc.
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。